Cite Filings / FHTX / 0001193125-20-276924

Feed Companies Filings Check

Sign in

424B4

Prospectus

Foghorn Therapeutics Inc. Filed 2020-10-26 Acc 0001193125-20-276924

Documents 1

424B4 Prospectus , d12441d424b4.htm

Around this filing

2020-10-29 SEC STAFF LETTER SEC Staff Letter Redacted Exhibit
2020-10-29 SC 13D Beneficial Ownership Report
2020-10-29 4 Chief Scientific Officer bought 5,500 shares at $16.00 ($88,000)
2020-10-28 4 Former 10% Owner bought 150,000 shares at $16.00 ($2,400,000)
2020-10-27 8-K Bylaws or fiscal year change
2020-10-26 424B4 Prospectus
2020-10-23 424B4 Prospectus

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading d12441d424b4.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…